Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A role of microRNA-149 in the prefrontal cortex for prophylactic actions of (R)-ketamine in inflammation model
Li Ma, Long Wang, Lijia Chang, et al.
Neuropharmacology (2022) Vol. 219, pp. 109250-109250
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

The antidepressant actions of ketamine and its enantiomers
Jenessa N. Johnston, Ioline D. Henter, Carlos A. Zarate
Pharmacology & Therapeutics (2023) Vol. 246, pp. 108431-108431
Open Access | Times Cited: 72
Effects of perioperative use of esketamine on postpartum depression risk in patients undergoing cesarean section: A randomized controlled trial
Qingren Liu, Qian-Kun Zong, Lili Ding, et al.
Journal of Affective Disorders (2023) Vol. 339, pp. 815-822
Open Access | Times Cited: 38
Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile
Jenessa N. Johnston, Maximillian Greenwald, Ioline D. Henter, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 4, pp. 103518-103518
Open Access | Times Cited: 36
Arketamine for cognitive impairment in psychiatric disorders
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1513-1525
Open Access | Times Cited: 32
Neuroinflammation through the vagus nerve-dependent gut–microbiota–brain axis in treatment-resistant depression
Kenji Hashimoto
Progress in brain research (2023), pp. 61-77
Closed Access | Times Cited: 31
Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions
Kenji Hashimoto, Mingming Zhao, Tingting Zhu, et al.
Journal of Anesthesia and Translational Medicine (2024) Vol. 3, Iss. 3, pp. 65-75
Open Access | Times Cited: 11
Repeated ( S )-ketamine administration ameliorates the spatial working memory impairment in mice with chronic pain: role of the gut microbiota–brain axis
Yubin Jiang, Xingming Wang, Jiawei Chen, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
(R)-(-)-Ketamine: The Promise of a Novel Treatment for Psychiatric and Neurological Disorders
Hana Shafique, Julie Demers, Julia Biesiada, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6804-6804
Open Access | Times Cited: 9
BNIP3L/NIX-mediated mitophagy alleviates passive stress-coping behaviors induced by tumor necrosis factor-α
Jia-Jing Lu, Pengfei Wu, Jin‐Gang He, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 12, pp. 5062-5076
Closed Access | Times Cited: 18
The Water Extract of Ampelopsis grossedentata Alleviates Oxidative Stress and Intestinal Inflammation
Zhao‐Jie Wang, Qian Jiang, Pingping Li, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 547-547
Open Access | Times Cited: 16
Exploring the multifaceted potential of (R)-ketamine beyond antidepressant applications
Senbing Zhang, Yanzhu Pu, Jianning Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Depression and antidepressant effects of ketamine and its metabolites: The pivotal role of gut microbiota
Hao Hua, Chaoli Huang, Hanyu Liu, et al.
Neuropharmacology (2022) Vol. 220, pp. 109272-109272
Closed Access | Times Cited: 27
A role of splenic heme biosynthesis pathway in the persistent prophylactic actions of arketamine in lipopolysaccharide-treated mice
Li Ma, Long Wang, Youge Qu, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Microbiota-Induced Epigenetic Alterations in Depressive Disorders Are Targets for Nutritional and Probiotic Therapies
Shabnam Nohesara, Hamid M. Abdolmaleky, Jin‐Rong Zhou, et al.
Genes (2023) Vol. 14, Iss. 12, pp. 2217-2217
Open Access | Times Cited: 13
A molecular perspective on mGluR5 regulation in the antidepressant effect of ketamine
Ola Sobhy A. Elmeseiny, Heidi Kaastrup Müller
Pharmacological Research (2024) Vol. 200, pp. 107081-107081
Open Access | Times Cited: 5
A role of gut–brain axis on prophylactic actions of arketamine in male mice exposed to chronic restrain stress
Li Ma, Akifumi Eguchi, Guilin Liu, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 238, pp. 173736-173736
Closed Access | Times Cited: 5
Repeated administration of esketamine ameliorates mechanical allodynia in mice with chemotherapy-induced peripheral neuropathy: A role of gut microbiota and metabolites
Wei-Wei Luan, Hanwen Gu, Di Qiu, et al.
Neurochemistry International (2025) Vol. 185, pp. 105961-105961
Closed Access
PROPHYLACTIC KETAMINE: CURRENT KNOWLEDGE AND FUTURE DIRECTIONS
Astrid M. Cardona-Acosta, Lyonna F. Parise, Carlos A. Bolaños‐Guzmán, et al.
Biological Psychiatry (2025)
Closed Access
Repeated use of 3,4-methylenedioxymethamphetamine is associated with the resilience in mice after chronic social defeat stress: A role of gut–microbiota–brain axis
Youge Qu, Akifumi Eguchi, Xiayun Wan, et al.
Psychiatry Research (2022) Vol. 320, pp. 115020-115020
Open Access | Times Cited: 19
Abnormal compositions of gut microbiota and metabolites are associated with susceptibility versus resilience in rats to inescapable electric stress
Xingming Wang, Akifumi Eguchi, Yūkō Fujita, et al.
Journal of Affective Disorders (2023) Vol. 331, pp. 369-379
Open Access | Times Cited: 12
Prophylactic effects of arketamine, but not hallucinogenic psychedelic DOI nor non-hallucinogenic psychedelic analog lisuride, in lipopolysaccharide-treated mice and mice exposed to chronic restrain stress
Guilin Liu, Li Ma, Youge Qu, et al.
Pharmacology Biochemistry and Behavior (2023) Vol. 233, pp. 173659-173659
Closed Access | Times Cited: 12
Epigenetic mechanisms of rapid-acting antidepressants
Antonio Inserra, Antonella Campanale, Tamim Rezai, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Stevioside mitigates metabolic dysregulation in offspring induced by maternal high-fat diet: the role of gut microbiota-driven thermogenesis
Jin Ye, Renjie Shi, Xiaoning Wu, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Effects of (S)-ketamine on depression-like behaviors in a chronic variable stress model: a role of brain lipidome
Cuihong Zhou, Xinxin Zhao, Xinxu Ma, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 7
Potential Molecular Mechanisms of Alcohol Use Disorder with Non-Coding RNAs and Gut Microbiota for the Development of Superior Therapeutic Application
Moeka Nakashima, Naoko Suga, Sayuri Yoshikawa, et al.
Genes (2024) Vol. 15, Iss. 4, pp. 431-431
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top